Thursday, September 29, 2016 3:42:24 PM
QBIO...another story stock...
BRCD...sounds real good...If you take the trade tell me what you got the contracts for. I have 4 students working on this stock...I wanted this stock because you can define your risk so well and we are now working on finding a good entry level with signals.
60 minute
Here is another story stock...has more risk...I'd like to see how price acts below $4.00...
QBIO Glaucoma Drug
Now is this HYPE...or not...?..
Our recommendation is that you secure your early position in Q BioMed Inc.(OTC: QBIO) right now. Life-changing gains are possible, now just think about what billions in annual revenues would mean for a burgeoning biotech company like Q BioMed, which currently with a tiny market cap of $16.28 million … a small investment could easily turn into 3X, 20X, etc. if given enough time and execution by the Company … based on the success of the MAN 01 Glaucoma drug and CATALYST alone.
We would not be surprised in the least if we see an early share-price double in the coming months as next round news is released on Q BioMed Inc. (OTC: QBIO), but first things first. In order to be in the game you must own QBIO. Don’t you end up kicking yourself later for missing out, so start your own research on Q BioMed, Inc. now and be sure to show this information to your broker. Everything we have noted above is easy to verify through publicly available sources and we are confident that you will agree that Q BioMed holds strong upside from current price levels.
...focus on Intraocular Eye Pressure (IOP), FDA approval for CATALYST, multiple pipelined drugs, and a renowned team of scientists and advisors, we see Q BioMed Inc. (OTC: QBIO) as an heirloom stock, one that can deliver expanding gains over the coming months and years. Do not hesitate on this one; buy it at the market today!
(Someone is HYPED up on something...
Daily...
60 minute
QBIO story stock...Glaucoma Drug
BRCD...sounds real good...If you take the trade tell me what you got the contracts for. I have 4 students working on this stock...I wanted this stock because you can define your risk so well and we are now working on finding a good entry level with signals.
60 minute
Here is another story stock...has more risk...I'd like to see how price acts below $4.00...
QBIO Glaucoma Drug
Now is this HYPE...or not...?..
Our recommendation is that you secure your early position in Q BioMed Inc.(OTC: QBIO) right now. Life-changing gains are possible, now just think about what billions in annual revenues would mean for a burgeoning biotech company like Q BioMed, which currently with a tiny market cap of $16.28 million … a small investment could easily turn into 3X, 20X, etc. if given enough time and execution by the Company … based on the success of the MAN 01 Glaucoma drug and CATALYST alone.
We would not be surprised in the least if we see an early share-price double in the coming months as next round news is released on Q BioMed Inc. (OTC: QBIO), but first things first. In order to be in the game you must own QBIO. Don’t you end up kicking yourself later for missing out, so start your own research on Q BioMed, Inc. now and be sure to show this information to your broker. Everything we have noted above is easy to verify through publicly available sources and we are confident that you will agree that Q BioMed holds strong upside from current price levels.
...focus on Intraocular Eye Pressure (IOP), FDA approval for CATALYST, multiple pipelined drugs, and a renowned team of scientists and advisors, we see Q BioMed Inc. (OTC: QBIO) as an heirloom stock, one that can deliver expanding gains over the coming months and years. Do not hesitate on this one; buy it at the market today!
(Someone is HYPED up on something...
Daily...
60 minute
QBIO story stock...Glaucoma Drug
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
